Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emergence and expansion of SARS-CoV-2 B.1.526 after identification in New York
Medini K. Annavajhala, Hiroshi Mohri, Pengfei Wang, et al.
Nature (2021) Vol. 597, Iss. 7878, pp. 703-708
Open Access | Times Cited: 119

Showing 26-50 of 119 citing articles:

Hospital wastewater surveillance for SARS-CoV-2 identifies intra-hospital dynamics of viral transmission and evolution
Medini K. Annavajhala, Anne L. Kelley, L Wen, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Flexible mitigation of epidemics by transport management
Fangzhou Liu, Dong Xue, Xinghu Yu, et al.
Chaos Solitons & Fractals (2025) Vol. 194, pp. 116211-116211
Open Access
High-throughput neutralization measurements correlate strongly with evolutionary success of human influenza strains
Caroline Kikawa, Andrea N. Loes, John Huddleston, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
The Development of SARS-CoV-2 Variants: The Gene Makes the Disease
Raquel Pérez-Gómez
Journal of Developmental Biology (2021) Vol. 9, Iss. 4, pp. 58-58
Open Access | Times Cited: 37
A monoclonal antibody that neutralizes SARS-CoV-2 variants, SARS-CoV, and other sarbecoviruses
Pengfei Wang, Ryan G. Casner, Manoj S. Nair, et al.
Emerging Microbes & Infections (2021) Vol. 11, Iss. 1, pp. 147-157
Open Access | Times Cited: 35
Computational prediction of the effect of mutations in the receptor-binding domain on the interaction between SARS-CoV-2 and human ACE2
İsmail Çeli̇k, Abbas Khan, Fenny Martha Dwivany, et al.
Molecular Diversity (2022) Vol. 26, Iss. 6, pp. 3309-3324
Closed Access | Times Cited: 25
SARS-CoV-2 variants: Impact on biological and clinical outcome
Shakuntala Mahilkar, Sachee Agrawal, Sakshi Chaudhary, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 25
Variants of SARS CoV-2: mutations, transmissibility, virulence, drug resistance, and antibody/vaccine sensitivity
Birgit M. Prü
Frontiers in Bioscience-Landmark (2022) Vol. 27, Iss. 2, pp. 065-065
Open Access | Times Cited: 22
Variant-specific introduction and dispersal dynamics of SARS-CoV-2 in New York City – from Alpha to Omicron
Simon Dellicour, Samuel L. Hong, Verity Hill, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 4, pp. e1011348-e1011348
Open Access | Times Cited: 15
Online Phylogenetics with matOptimize Produces Equivalent Trees and is Dramatically More Efficient for Large SARS-CoV-2 Phylogenies than de novo and Maximum-Likelihood Implementations
Alexander Krämer, Bryan Thornlow, Cheng Ye, et al.
Systematic Biology (2023) Vol. 72, Iss. 5, pp. 1039-1051
Open Access | Times Cited: 15
The End or a New Era of Development of SARS-CoV-2 Virus: Genetic Variants Responsible for Severe COVID-19 and Clinical Efficacy of the Most Commonly Used Vaccines in Clinical Practice
Dimitrina Miteva, Meglena Kitanova, Hristiana Batselova, et al.
Vaccines (2023) Vol. 11, Iss. 7, pp. 1181-1181
Open Access | Times Cited: 13
SARS-CoV-2 variant dynamics across US states show consistent differences in effective reproduction numbers
Marlin Figgins, Trevor Bedford
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 31
Cross-Neutralization of Emerging SARS-CoV-2 Variants of Concern by Antibodies Targeting Distinct Epitopes on Spike
Siriruk Changrob, Yanbin Fu, Jenna J. Guthmiller, et al.
mBio (2021) Vol. 12, Iss. 6
Open Access | Times Cited: 31
SARS CoV-2 Delta variant exhibits enhanced infectivity and a minor decrease in neutralization sensitivity to convalescent or post-vaccination sera
Alona Kuzmina, Seraj Wattad, Yara Khalaila, et al.
iScience (2021) Vol. 24, Iss. 12, pp. 103467-103467
Open Access | Times Cited: 30
Estimating the strength of selection for new SARS-CoV-2 variants
Christiaan H. van Dorp, Emma E. Goldberg, Nicolas Hengartner, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 30
COVID-19 Genetic Variants and Their Potential Impact in Vaccine Development
Vo Van Giau, Eva Bagyinszky, Seong Soo A. An
Microorganisms (2022) Vol. 10, Iss. 3, pp. 598-598
Open Access | Times Cited: 20
DNA-delivered antibody cocktail exhibits improved pharmacokinetics and confers prophylactic protection against SARS-CoV-2
Elizabeth M. Parzych, Jianqiu Du, Ali Ali, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 20
Molecular variants of SARS-CoV-2: antigenic properties and current vaccine efficacy
Amirmasoud Rayati Damavandi, Razieh Dowran, Sarah Al Sharif, et al.
Medical Microbiology and Immunology (2022) Vol. 211, Iss. 2-3, pp. 79-103
Open Access | Times Cited: 19
COVID-19 pandemic: the delta variant, T-cell responses, and the efficacy of developing vaccines
Biswajit Biswas, Shagnik Chattopadhyay, Sayantee Hazra, et al.
Inflammation Research (2022) Vol. 71, Iss. 4, pp. 377-396
Open Access | Times Cited: 18
Structural bioinformatics analysis of SARS-CoV-2 variants reveals higher hACE2 receptor binding affinity for Omicron B.1.1.529 spike RBD compared to wild type reference
Vedat Durmaz, Katharina Köchl, A. Krassnigg, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 18
Multiplex Fragment Analysis for Flexible Detection of All SARS-CoV-2 Variants of Concern
Andrew E. Clark, Zhaohui Wang, Emily Ostman, et al.
Clinical Chemistry (2022) Vol. 68, Iss. 8, pp. 1042-1052
Open Access | Times Cited: 17
SARS-CoV-2 Variants Associated with Vaccine Breakthrough in the Delaware Valley through Summer 2021
Andrew D. Marques, Scott Sherrill-Mix, J.K. Everett, et al.
mBio (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 16
Advances in Pathogenesis, Progression, Potential Targets and Targeted Therapeutic Strategies in SARS-CoV-2-Induced COVID-19
Hong Zhou, Wei‐Jian Ni, Wei Huang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 16
Fluorogenic reporter enables identification of compounds that inhibit SARS-CoV-2
Junjiao Yang, Yinghong Xiao, Peter V. Lidsky, et al.
Nature Microbiology (2023) Vol. 8, Iss. 1, pp. 121-134
Open Access | Times Cited: 10
Data-driven mechanistic framework with stratified immunity and effective transmissibility for COVID-19 scenario projections
Przemyslaw Porebski, Srinivasan Venkatramanan, Aniruddha Adiga, et al.
Epidemics (2024) Vol. 47, pp. 100761-100761
Open Access | Times Cited: 3

Scroll to top